Earth Science Tech Inc. (OTCQB: ETST), a healthcare, pharmacy, and telemedicine holding company, has uplisted to the OTCQB Venture Market as of Sept. 17, 2026. This move marks a significant milestone in the company’s fiscal 2027 growth strategy, following a strong first quarter and two strategic acquisitions.
The company reported a 3% increase in revenue to $9.0 million and a 57% rise in net income to $715,697 for its first quarter. These financial gains come alongside the acquisitions of Meduvo LLC, a compounding pharmacy, and Zoolzy LLC, a pharmaceutical distributor. These acquisitions are expected to expand Earth Science Tech’s opportunities in both human therapeutics and animal health, furthering its integrated healthcare platform.
At its annual shareholder meeting on Aug. 31, investors approved several key measures, including support for potential future uplisting to the Nasdaq or NYSE, the planned retirement of the dual-class voting structure, and a new non-dilutive executive compensation framework. These developments reflect the company’s focus on improving operational efficiency, broadening its business portfolio, enhancing corporate governance, and positioning itself for continued growth.
Earth Science Tech operates as a diversified holding company in the health and wellness sector. Its principal strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company’s value proposition lies in seamless patient care from consultation to fulfillment, achieved through specialized subsidiaries. For more information, visit www.EarthScienceTech.com. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
The announcement was covered by BioMedWire, a specialized communications platform focused on biotechnology, biomedical sciences, and life sciences. BioMedWire is one of over 75 brands within the Dynamic Brand Portfolio at IBN, which delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. For more information, visit https://www.BioMedWire.com. Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer.
This strategic uplisting and expansion underscore Earth Science Tech’s commitment to enhancing shareholder value and solidifying its position in the competitive healthcare and telemedicine landscape.
